Model
Edge
Alnylam Pharmaceuticals, Inc.
0001740730
Filing Type
144
Filing Date
9/8/2025
Updated
9/9/25, 2:05 PM
Copy Ref
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities